FDA
The new article outlines the key points regarding patient preference information and its use in the context of the product lifecycle.
FDA
The article outlines the basics of chemical analysis in the context of biocompatibility of medical devices.
FDA
The new article provides further clarifications related to gathering additional information.
FDA
The new article highlights the key aspects related to the way test articles should be extracted in order to ensure the accuracy and reliability of further assessment.
FDA
The new article explains in detail the way chemical analysis should be conducted in order to ensure any and all key matters are addressed properly.
FDA
The final article of the cycle provides additional clarifications regarding the matters related to data reporting.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
